DDi has been chosen by a UK-based $2B medical-device company to streamline global regulatory strategy, intelligence operations, and assessments - boosting compliance, accelerating market readiness, and powered by DDi’s advanced Visu platform.

DDi unveils AI Agents for regulation and planning.

DDi enhances its Visu platform with AI-driven project management tools, offering increased efficiency, real-time insights, and risk mitigation for pharma, biotech, and medical device industries.